Our impact
Delivering today’s innovation with tomorrow in mind
At Zealand Pharma, we are committed to positively impacting lives and operating a responsible and sustainable business. We embed sustainability across our business to deliver meaningful progress for patients today and enable future therapies, without compromising the needs of future generations
Our sustainability strategy
To us, sustainability is both a responsibility and an opportunity: to deliver meaningful progress for patients today while safeguarding the needs of future generations.
As we progress toward becoming a generational biotech and a leader in obesity and metabolic health, we continue to strengthen how sustainability is integrated into our strategy, decision-making, and day-to-day operations. This enables us to scale responsibly as our pipeline, partnerships, and global footprint expand.
Our sustainability strategy is based on three core pillars:
Our patients
Advancing health, safety, and access through responsible research and development
Our people
Empowering innovation and wellbeing through our unique culture, high engagement, and inclusion
Our operations
Driving responsible growth through decisive climate action, strong ethics, and robust governance
Together, these pillars guide our priorities and actions, as we continue to grow
Our patients
Patients are at the heart of everything we do. One of our most important contributions to a better society is improving health and quality of life for our patients.
We continue to advance our differentiated clinical pipeline with a strong focus on obesity and metabolic health, while maintaining our long standing commitment to rare diseases. By combining more than 25 years of expertise with advanced technologies and strategic partnerships, we aim to address serious unmet medical needs and deliver lasting benefits for patients.
Patient health and safety
Patient health and safety are central to our business and the trust in our medicines.
We apply high quality and safety standards with strong systems and governance, to ensure patient safety, data integrity, and ethical standards are never compromised.
Transparency in clinical research
Transparency is vital to patient safety and further innovation, and we remain dedicated to share data and insights with the scientific community, to advance innovation in the industry and enable better patient treatments.
Access to Medicine
Ensuring future therapies reach patients is core to our purpose. We work with access through clinical development, partnerships, and early commercialization planning, and ensure Expanded Access Programs of our drug candidates to serve patients who need treatments, before products are available on the market.
Our people
Empowering sustainable innovation
We foster a workplace where people can grow, collaborate, and make a meaningful difference. Our culture is built on collaboration, empowerment, and trust, which supports both innovative research and development, and enables long‑term business success.
Engagement and development
We prioritize a working culture with a large focus on well-being, flexibility, and continuous development which fosters exceptionally high engagement, motivation and development for our people.
Diversity, equity, and inclusion
We are committed to fostering an inclusive workplace that values diverse perspectives, backgrounds, and experiences. Diversity, equity, and inclusion are embedded in our recruitment practices, leadership development, and core people processes. We believe diverse teams drive better decisions, stronger innovation, and improved outcomes for patients and society.
Our operations
Responsible growth and strong governance
As a growing biotech company, we take full responsibility for the environmental and ethical impact of our operations and value chain
Climate action
We view climate change as one of the defining challenges of our generation, and we take decisive action to mitigate climate change.
Our Board approved Climate Transition Plan aligns Zealand Pharma with a 1.5°C pathway in accordance with the Paris Agreement, and our decarbonization targets are approved by the Science Based Targets initiative (SBTi)
Responsible supply chain
We set high standards for our suppliers, and we work closely with partners to collectively promote responsible business conduct across our value chain
Ethics and compliance
We operate according to high ethical standards and maintain robust safeguards and clear policies to prevent corruption, bribery, and non compliance.
Responsible use of data and AI
As we expand the use of advanced technologies and AI, we apply robust cybersecurity measures, and strong data ethics. This ensures responsible data use while enabling accelerated innovation across research and operations.
Governance and accountability
Sustainability owned at the top
Sustainability at Zealand Pharma is owned at the highest level of the organization.
The Board of Directors sets the overall corporate and sustainability strategy, while execution is anchored in Corporate Management. This ensures sustainability is embedded into strategic decisions and operational priorities across the business.
Incentives and accountability
Sustainability performance, including climate target, is integrated into company wide goals and incentive schemes for all employees, including Corporate Management. This reinforces accountability and aligns day to day decisions with long term sustainability objectives
Global frameworks
Zealand Pharma is a participant in the UN Global Compact, committing to support the Ten Principles on human rights, labor, environment, and anti-corruption. The Science Based Targets initiative (SBTi) has approved Zealand Pharma’s near-term science-based greenhouse gas (GHG) emissions reduction target. We have also committed to set a long-term science-based net zero target with the SBTi, in line with reaching net zero by 2050.
Patient stories
